WuXi Biologics (Caym...
SEHK:2269
HK$ 34,98
HK$0,00 (0,00%)
34,98 HK$
HK$0,00 (0,00%)
End-of-day quote: 04/07/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

HK$1,48
Earnings Per Share
HK$6,03
Revenue Per Share
45,98%
Gross Margin %
HK$144,73 B
Market Cap
HK$0,19 B
Long-Term Debt
Earnings Per Share
HK$1,48
Revenue Per Share
HK$6,03
Gross Margin %
45,98%
Market Cap
HK$144,73 B
Long-Term Debt
HK$0,19 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
EPS Earnings Per Share HK$1,48 HK$1,19 HK$1,06 HK$1,13 HK$0,75 HK$0,41 HK$0,30 HK$0,19 HK$0,12 HK$0,05
Earnings Earnings HK$5,95B HK$4,89B HK$4,48B HK$4,77B HK$3,17B HK$1,67B HK$1,17B HK$698,79M HK$418,70M HK$144,60M
RPS Revenue Per Share HK$6,03 HK$4,84 HK$4,03 HK$3,61 HK$2,44 HK$1,37 HK$1,03 HK$0,69 HK$0,46 HK$0,00
Revenue Revenue HK$24,25B HK$19,87B HK$17,03B HK$15,27B HK$10,29B HK$5,61B HK$3,98B HK$2,53B HK$1,62B HK$0,00M
OCF Operating Cash Flow HK$7,36B HK$5,55B HK$4,67B HK$5,54B HK$3,40B HK$1,85B HK$1,21B HK$761,61M HK$360,28M HK$0,00M
FCF Free Cash Flow HK$2,08B HK$1,37B HK$964,86M HK$-326,72M HK$-3,11B HK$-4,18B HK$-2,00B HK$-578,98M HK$-310,32M HK$0,00M
OM Operating Margin 30,50% 24,55% 23,09% 28,49% 30,81% 26,77% 23,80% 20,61% 25,37% 0,00%
GM % Gross Margin % 45,98% 40,97% 40,08% 44,04% 46,93% 45,04% 41,64% 40,16% 40,80% 0,00%
FCFS Free Cash Flow Per Share HK$0,00 HK$0,34 HK$0,15 HK$-0,08 HK$-0,74 HK$-1,05 HK$-0,54 HK$-0,25 HK$-0,10 HK$0,00
LT Debt Long-Term Debt HK$188,49M HK$213,79M HK$1,57B HK$1,46B HK$640,51M HK$1,84B HK$1,40B N/A N/A HK$866,00M
Sha. Stocks 4.020,34M 4.105,94M 4.222,73M 4.225,26M 4.224,38M 4.084,76M 3.883,58M 3.677,82M 3.489,2M 2.892M
×